Paper looking at the challenges facing professionals in health and social care in dealing with service users with dual diagnosis, the co-existence of substance misuse and mental health problems.
The government published the new drug strategy in February 2008. Since then there has been a great deal of progress, with drug use now down to its lowest level in more than a decade. However, there is still more to be done and the government is determined that the action it takes should meet the priorities and needs of local communities.
Good mental health is fundamental to the well-being and prosperity of England. In the last decade, greater investment and reforms have transformed mental health care, but now we need to go further.
This easy read booklet is a shorter version of New Horizons: Towards a shared vision for mental health. Which will help improve the services for adults with mental health problems better in the future, and help everyone have better mental health.
An essay on the definition of 'recovery' in substance misuse.
What does the public really think about addiction and its treatment? A report on the findings of a DrugScope/ICM poll.
Naltrexone is a medication which blocks the effects of heroin and other opiate-type drugs. Its considerable potential in helping to prevent post-detoxification relapse has not been realised because patients generally refuse to take it or quickly discontinue.
Tackling drug misuse in Scotland is one of the Scottish Executive’s key priorities. The Executive has adopted Tackling Drugs in Scotland: Action in Partnership as the forward drugs strategy for Scotland.
This plan sets out how the Executive will play its part in beating drugs in terms of young people, communities and treatment.
Second annual report which sets out the progress made in 2002 across all 4 pillars of the Executive’s drugs strategy, namely, young people, communities, treatment and availability.
The Alzheimer's Society is the UK's leading care and research charity for people with dementia, their families and carers. They produce information and advice sheets to support those affected by dementia.
This information sheet outlines the symptoms and causes of Alzheimer’s disease, and describes what treatments are currently available.
These guidelines are a revision of 'Drug Misuse and Dependence: Guidelines on Clinical Management' published in 1991. A comprehensive set of guidance is provided for doctors in the assessment, treatment and management of drug users and drug misuse.